Acute Lymphocytic Leukemia: Critical Insights

Hear critical insights from multidisciplinary cancer team members with expertise in treating older adolescents and adults with acute lymphocytic leukemia (ALL). Using a case-based approach, these experts discuss current treatment strategies for Ph(+) and Ph(-) patients, and take a closer look at the role of minimal residual disease (MRD) for prognosis and treatment selection. Special attention is paid to identification and management of cytokine release syndrome (CRS), along with pertinent drug-drug interactions when using Bcr-Abl tyrosine kinase inhibitors (TKIs) as part of combination treatment. If you have any questions along the way please contact  Monique Dawkins, Assistant Director, Provider Education for ACCC.